Skip to main content

Advertisement

Log in

Doctors’ attitudes about prescribing and knowledge of the costs of common medications

  • Original Article
  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Abstract

Introduction

Compliance with medical therapy may be compromised because of the affordability of medications. Inadequate physician knowledge of drug costs may unwittingly contribute to this problem.

Methods

We measured attitudes about prescribing and knowledge of medication costs by written survey of medical and surgical non consultant hospital doctors and consultants in two University teaching hospitals (n = 102). Sixty-eight percent felt the cost of medicines was an important consideration in the prescribing decision, however, 88% often felt unaware of the actual costs. Only 33% had easy access to drug cost data, and only 3% had been formally educated about drug costs. Doctors' estimates of the cost of a supply of ten commonly used medications were accurate in only 12% of cases, too low for 50%, and too high for 38%.

Conclusions

Interventions are needed to educate doctors about drug costs and provide them with reliable, easily accessible cost information in real-world practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References:

  1. Shulman NB, Martinez B, Brogan D, Carr AA, Miles CG (1986) Financial cost as an obstacle to hypertension therapy. Am J Public Health 76(9):1105–1108

    Article  PubMed  CAS  Google Scholar 

  2. http://www.budget.gov.i.e/

  3. Mishra SK, Satpathy R (2001) Physicians’ attitudes about prescribing and knowledge of the costs of common medications. Arch Intern Med 161(10):1352–1353. doi:10.1001/archinte.161.10.1352

    Article  PubMed  CAS  Google Scholar 

  4. Reichert S, Simon T, Halm EA (2000) Physicians’ attitudes about prescribing and knowledge of the costs of common medications. Arch Intern Med 160(18):2799–2803. doi:10.1001/archinte.160.18.2799

    Article  PubMed  CAS  Google Scholar 

  5. Glickman L, Bruce EA, Caro FG, Avorn J (1994) Physicians’ knowledge of drug costs for the elderly. J Am Geriatr Soc 42:992–996

    PubMed  CAS  Google Scholar 

  6. Hoffman J, Barefield FA, Ramamurthy S (1995) A survey of physician knowledge of drug costs. J Pain Symptom Manage 10:432–435. doi:10.1016/0885-3924(95)00018-T

    Article  PubMed  CAS  Google Scholar 

  7. Fowkes FG (1985) Doctors’ knowledge of the costs of medical care. Med Educ 19:113–117

    Article  PubMed  CAS  Google Scholar 

  8. Allan GM, Innes G (2002) Family practice residents’ awareness of medical care costs in British Columbia. Fam Med 34:106–111

    Google Scholar 

  9. Innes G, Grafstein E, McGrogan J (2000) Do emergency physicians know the costs of medical care? CJEM 2:95–102

    PubMed  CAS  Google Scholar 

  10. Health Division OECD (2006) OECD health data. 6 October 2006 Available: http://www.oecd.org

  11. Court rules in favour of pharmacies in payment row Available: https://www.irishtimes.com/newspaper/breaking/2008/0911/breaking55.htm

  12. Garrison L, Towse A (2003) The drug budget silo mentality in Europe: an overview. Value Health 6:S1–S9. doi:10.1046/j.1524-4733.6.s1.1.x

    Article  PubMed  Google Scholar 

  13. Seay M, Varma P (2005) Pharmaceuticals: Pharmaceutical cost controls, 2005. End of year issue brief. Issue Brief Health Policy Track Serv 31:1–20

    Google Scholar 

  14. Maxwell M, Heaney D, Howie JGR, Noble S (1993) General practice fundholding: observations of prescribing patterns and costs using the defined daily dose method. BMJ 307:1190–1195

    Article  PubMed  CAS  Google Scholar 

  15. Aaserud M, Dahlgren A, Kosters J, Oxman A, Ramsay C et al (2006) Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies. Cochrane Database Syst Rev 2006

  16. Lee TH (2004) “Me-too” products—friend or foe? N Engl J Med 350:211–212. doi:10.1056/NEJMp038215

    Article  PubMed  CAS  Google Scholar 

  17. Cox ER, Jernigan C, Coons SJ, Draugalis JL (2001) Medicare beneficiaries’ management of capped prescription benefits. Med Care 39:296–301. doi:10.1097/00005650-200103000-00009

    Article  PubMed  CAS  Google Scholar 

  18. Hsu J, Price M, Huang J, Brand R, Fung V et al (2006) Unintended consequences of caps on medicare drug benefits. N Engl J Med 354:2349–2359. doi:10.1056/NEJMsa054436

    Article  PubMed  CAS  Google Scholar 

  19. Tamblyn R, Laprise R, Hanley JA, Abrahamowicz M, Scott S et al (2001) Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 285:421–429. doi:10.1001/jama.285.4.421

    Article  PubMed  CAS  Google Scholar 

  20. Piette JD, Heisler M, Wagner TH (2004) Cost-related medication underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med 164:1749–1755. doi:10.1001/archinte.164.16.1749

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Roche-Nagle.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McGuire, C., King, S., Roche-Nagle, G. et al. Doctors’ attitudes about prescribing and knowledge of the costs of common medications. Ir J Med Sci 178, 277–280 (2009). https://doi.org/10.1007/s11845-009-0276-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-009-0276-x

Keywords

Navigation